Nader Halim, Innervace CEO
Deerfield backs a Penn spinout aiming to shake up Parkinson's treatments using stem cells, brain surgery
Unlike in other neurodegenerative diseases, such as Alzheimer’s, the pathology of Parkinson’s is relatively well-understood. Researchers have known for decades that the disease affects the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.